This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
BioFire Diagnostics, LLC
BioFire Diagnostics, LLC, a prominent player in the molecular diagnostics industry, is headquartered in the United States. Founded in 1990, the company has established itself as a leader in infectious disease testing, particularly through its innovative BioFire FilmArray® system. This cutting-edge technology allows for rapid, comprehensive testing of multiple pathogens from a single patient sample, setting BioFire apart in the market. With a strong presence in North America and expanding operations globally, BioFire Diagnostics has achieved significant milestones, including FDA approvals for various products. The company’s commitment to accuracy and speed in diagnostics has earned it a notable reputation among healthcare professionals, making it a trusted partner in clinical laboratories. As a subsidiary of bioMérieux, BioFire continues to push the boundaries of diagnostic solutions, enhancing patient care worldwide.
DitchCarbon Score
How does BioFire Diagnostics, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BioFire Diagnostics, LLC's score of 73 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
BioFire Diagnostics, LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of bioMérieux S.A., which cascades its climate commitments and performance metrics down to BioFire. While no direct emissions data is available, BioFire's climate initiatives are influenced by the targets set by its parent company, bioMérieux S.A. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which aim to enhance transparency and accountability in corporate climate action. As a subsidiary, BioFire aligns with the broader sustainability goals of bioMérieux, which are designed to reduce greenhouse gas emissions across various scopes. However, specific reduction targets or achievements for BioFire Diagnostics have not been disclosed. In summary, while BioFire Diagnostics, LLC does not provide its own emissions data or specific reduction targets, it is part of a corporate family that is actively engaged in climate commitments through bioMérieux S.A.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 31,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 241,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
BioFire Diagnostics, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
